A mini-review on drug delivery through wafer technology: Formulation and manufacturing of buccal and oral lyophilizates

Publication date: Available online 3 May 2019Source: Journal of Advanced ResearchAuthor(s): Juliana Souza Ribeiro Costa, Karen de Oliveira Cruvinel, Laura Oliveira-NascimentoAbstractA great number of patients have difficulty swallowing or needle fear. Therefore, buccal and orodispersible dosage forms (ODFs) represent an important strategy to enhance patient compliance. Besides not requiring water intake, swallowing or needles, these dosage forms allow drug release modulation. ODFs include oral lyophilizates or wafers, which present even faster disintegration than its compressed counterparts. Lyophilization can also produce buccal wafers that adhere to mucosa for sustained drug release. Due to the subject relevance and recent research growth, this review focused on oral lyophilizate production technology, formulation features, and therapy gains. It includes Critical Quality Attributes (CQA) and Critical Process Parameters (CPP) and discusses commercial and experimental examples. In sum, the available commercial products promote immediate drug release mainly based on biopolymeric matrixes and two production technologies. Therapy gains include substitution of traditional treatments depending on parenteral administration and patient preference over classical therapies. Experimental wafers show promising advantages as controlled release and drug enhanced stability. All compiled findings encourage the development of new wafers for several diseases and drug molecules.Graphical abstr...

Source: Journal of Advanced Research - May 3, 2019 Category: Research Source Type: research